A "friendly merger" seems sensible, but can't see this at premium to EKA price as some think. EKA need more cash, so future potential dilution will enter any calcs. But a merger will be good for shareholders of both companies, and will ultimately lead to a takeover by a third party at a much higher premium IMO.
- Forums
- ASX - By Stock
- ADI
- Ann: Sugarloaf Production Update
Featured News
Add ADI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online